Search Results - "Emel’yanova, G. S."

Sunitinib in pancreatic neuroendocrine tumors. Clinical case by Markovich, A. A., Kuznetsova, A. A., Dronova, E. L., Emel’yanova, G. S.

“…The article describes a rare clinical case. Progression of the disease in the form of multiple metastases to the liver, lymph nodes of the hepatoduodenal…”
Get full text

Potential for use sunitinib in pancreatic neuroendocrine tumors by Markovich, A. A., Kuznetsova, A. A., Gorbunova, V. A., Orel, N. F., Odintsova, A. S., Emelyanova, G. S., Kuzminov, A. E.

“…The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib…”
Get full text

THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT by Gorbunova, V. A., Pigarova, E. A., Rozhinskaya, L. Ya, Voronkova, I. A., Krupinova, Yu. A., Emel’yanova, G. S., Kruglova, L. S., Shiryaev, S. V., Dolgushin, M. B., Bilik, M. E., Kobyakova, E. A., Komov, D. V.

“…Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary…”
Get full text

Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors by A A Markovich, A E Kuzminov, N F Orel, A S Odintsova, G S Emelyanova, V A Gorbunova

“…Everolimus is the targeted drug approved for the treatment of neuroendocrine tumors (NET). Efficacy of everolimus in combination with octreotide-depo has been…”
Get full text

Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide by Emelyanova, G.S., Kuzminov, A.E., Orel, N.F., Odintsova, A.S., Markovich, A.A., Kuznetsova, A.A., Gorbunova, V.A.

“…Somatostatin analogs plays a key role in the treatment of disseminated well-differentiated functioning and nonfunctioning neuroendocrine tumors (NET). Its…”
Get full text